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Abstract
Background
Comorbid depression is a significant challenge for safety-net primary care systems. Team-based
collaborative depression care is effective, but complex system factors in safety-net organizations impede
adoption and result in persistent disparities in outcomes. Diabetes-Depression Care-management Adoption
Trial (DCAT) evaluated whether depression care could be significantly improved by harnessing
information and communication technologies to automate routine screening and monitoring of patient
symptoms and treatment adherence and allow timely communication with providers.
Objective
The aim of this study was to compare 6-month outcomes of a technology-facilitated care model with a
usual care model and a supported care model that involved team-based collaborative depression care for
safety-net primary care adult patients with type 2 diabetes.
Methods
DCAT is a translational study in collaboration with Los Angeles County Department of Health Services,
the second largest safety-net care system in the United States. A comparative effectiveness study with
quasi-experimental design was conducted in three groups of adult patients with type 2 diabetes to compare
three delivery models: usual care, supported care, and technology-facilitated care. Six-month outcomes
included depression and diabetes care measures and patient-reported outcomes. Comparative treatment
effects were estimated by linear or logistic regression models that used generalized propensity scores to
adjust for sampling bias inherent in the nonrandomized design.
Results
DCAT enrolled 1406 patients (484 in usual care, 480 in supported care, and 442 in technology-facilitated
care), most of whom were Hispanic or Latino and female. Compared with usual care, both the supported
care and technology-facilitated care groups were associated with significant reduction in depressive
symptoms measured by scores on the 9-item Patient Health Questionnaire (least squares estimate, LSE:
usual care=6.35, supported care=5.05, technology-facilitated care=5.16; P value: supported care vs usual
care=.02, technology-facilitated care vs usual care=.02); decreased prevalence of major depression (odds
ratio, OR: supported care vs usual care=0.45, technology-facilitated care vs usual care=0.33; P value:
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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supported care vs usual care=.02, technology-facilitated care vs usual care=.007); and reduced functional
disability as measured by Sheehan Disability Scale scores (LSE: usual care=3.21, supported care=2.61,
technology-facilitated care=2.59; P value: supported care vs usual care=.04, technology-facilitated care vs
usual care=.03). Technology-facilitated care was significantly associated with depression remission
(technology-facilitated care vs usual care: OR=2.98, P=.04); increased satisfaction with care for emotional
problems among depressed patients (LSE: usual care=3.20, technology-facilitated care=3.70; P=.05);
reduced total cholesterol level (LSE: usual care=176.40, technology-facilitated care=160.46; P=.01);
improved satisfaction with diabetes care (LSE: usual care=4.01, technology-facilitated care=4.20; P=.05);
and increased odds of taking an glycated hemoglobin test (technology-facilitated care vs usual care:
OR=3.40, P<.001).
Conclusions
Both the technology-facilitated care and supported care delivery models showed potential to improve 6month depression and functional disability outcomes. The technology-facilitated care model has a greater
likelihood to improve depression remission, patient satisfaction, and diabetes care quality.
Keywords: primary care, disease management, depression, diabetes mellitus, health information
technology, telemedicine, comparative effectiveness research, propensity score, population health, patient
reported outcome measures

Introduction
Depression Care in Underserved Populations
Depression, an underdiagnosed comorbidity for those with chronic illness [1], impairs functional status
and worsens clinical outcomes, including morbidity and mortality; it also increases cost [2-5]. Diabetes
doubles the risk of depression relative to the general population; 10% to 15% of adults with diabetes also
have major depressive disorder [6,7]. The relationship between diabetes and depression might be
bidirectional [8,9]. Depression with diabetes may significantly worsen the course of both disorders,
leading to reduced functioning and quality of life [8-11].
Low-income, culturally diverse populations with chronic illnesses have an even higher risk of depression
[7,12,13]. Hispanics and Latinos have a higher prevalence of diabetes compared with non-Hispanic whites
[14] and are less likely to meet glycated hemoglobin (HBA1c) and serum cholesterol goals [15]. Racial and
ethnic minority populations also experience disparities in terms of mental health care, including
appropriate mental health diagnosis, counseling, antidepressant medication prescriptions, and depression
care follow-up [16-23]. Hispanics and Latinos are less than half as likely as non-Hispanic whites to receive
guideline-level depression care [20].
Research has shown that there are effective ways to reduce these disparities. For example, there is growing
evidence that a team-based collaborative depression care model is effective in improving care for lowincome patients (including racial and ethnic minority populations) with chronic illnesses [24-27]. The US
Preventive Services Task Force recommends depression screening, and an adaptive treatment approach has
been shown to be effective in helping patients find successful antidepressant options or psychotherapy
[28,29].
Safety-net primary care clinics are the preferred venue for underserved patients to access depression care
because it is a common point of service delivery [30-32]. However, these settings encounter a complex
mix of patient, provider, and health system factors that can impede the adoption of evidence-based
collaborative depression care and result in persistent disparities in depression outcomes [33].

https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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Safety-net systems organize and deliver a significant level of health care and other related services to
uninsured, Medicaid, and other vulnerable populations [34]. Safety-net primary care providers often find it
challenging to engage patients with major depression, particularly when it is accompanied by chronic
illnesses, because the patient must participate in active and ongoing depression symptom assessment and
management in addition to managing the other medical conditions [16,33,35-37]. Concurrently, minority
patients are less likely to voluntarily report depressive symptoms, may view depression as a moral
weakness or character flaw rather than an illness, and may be more likely to ascribe symptoms of
depression to a physical illness [33,38]. Therefore, low-income, predominantly minority patients in safetynet care systems often miss out on depression diagnosis and follow-up assessments [33,39].
Diabetes-Depression Care-Management Adoption Trial
The Diabetes-Depression Care-management Adoption Trial (DCAT) is a translational study in a large
safety-net system of primary care settings. The study compared a technology-facilitated care (TC) model
with a usual care (UC) model and a supported care (SC) model to assess whether technology could
facilitate the adoption of collaborative depression care for patients with type 2 diabetes. The DCAT TC
model is an information and communication technology (ICT)–facilitated care management approach that
harnesses automated telephone assessment (ATA) technology and integrates it with a disease management
registry (DMR) system to automate key aspects of depression care. The UC model is standard care in a
safety-net system in which primary care physicians (PCPs) develop individualized treatment plans for
depression and diabetes care. The SC model is a team-based collaborative care management approach that
involves care team staff members to provide depression and diabetes care.
The DCAT study is expected to fill two important gaps in current collaborative depression care
implementation research. First, existing studies largely rely on labor-intensive, team-based SC approaches
to implement collaborative depression care [24-27,40-43]. There is evidence that this SC model is effective
and can be cost-effective compared with UC [24-27,44-47]. However, it is challenging for SC teams to
integrate depression comorbidity care when patients are presented with other medical conditions because
of the intensive labor and time needed to proactively screen for depression, follow up on treatment, and
monitor and manage long-term care [33,41,48]. By relieving providers in resource-constrained safety-net
clinics from many labor-intensive tasks such as collecting, summarizing, and reviewing individual or
aggregate patient data to facilitate care, automation can facilitate the adoption of collaborative depression
care. Therefore, DCAT tested ICT that automated critical information collection and processing for
depression care tasks, including (1) Depression assessments and symptom monitoring, (2) Patient selfmanagement behavior prompting, (3) Optimization of treatment follow-up, and (4) provider collaborative
communication.
Second, existing research has not fully addressed ways to develop a patient-centered approach to
implement collaborative depression care for low-income, predominantly minority safety-net patient
populations. Prior studies have demonstrated that the team-based approach can effectively implement
collaborative depression care in safety-net environments [24-27]; DCAT built on this evidence by applying
the ICT to further address language, time, and stigma barriers [33,41,48] affecting safety-net patients.
DCAT accomplished this by customizing calls with the patient’s preferred language and call time, making
multiple attempts (if needed) to connect with the patient, and establishing a private and machine-only
venue to report sensitive depression measures to reduce social desirability bias [49-51]. About 80% of the
patients agreed or strongly agreed that the DCAT-tested ICT was easy to use (86.2%, 94/109), nonintrusive
(87.1%, 95/109), and private and secure (75.9%, 82/108) [51].
Paper Purpose and Hypothesis
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DCAT-related improvements have been reported in several publications, including trial design [33], TC
technology design and evaluation [52], patient acceptance of the technology [51], patient engagement [50],
provider implementation reactions [53], depression risk profiling and prediction [54,55], and costeffectiveness analysis (unpublished data, 2018, [56]). This paper reports DCAT-related depression
symptom and diabetes care outcomes after 6 months. In addition, to provide the patients’ perspective on
treatment benefits, this paper includes patient-reported outcomes, including physical and mental wellbeing, functional impairment, and satisfaction with care [57].
The main hypothesis of the paper is that, compared with the UC group, both the TC and SC groups will
have statistically significant greater improvement in depression symptoms, diabetes care processes and
outcomes, and patient-reported outcomes. TC uses an ATA system to ease the adoption of collaborative
depression care rather than direct clinical intervention with patients; therefore, although the researchers
have no hypothesis on how TC outcomes will compare with SC outcomes, this paper also explores
whether the TC group will have better outcomes than the SC group.

Methods
Diabetes-Depression Care-Management Adoption Trial Study Design
DCAT is a translational study conducted in collaboration with Los Angeles County Department of Health
Services (LACDHS), the second largest safety-net care system in the United States. Institutional review
board approval was obtained from the University of Southern California, the Olive View–University of
California Los Angeles Medical Center, and the Los Angeles Biomedical Research Institute.
Study Sites and Intervention Period The study used a quasi-experimental comparative effectiveness

design to compare three delivery models in three groups: UC, SC, and TC. Eight clinics were selected to
participate in the study based on criteria that reflected geographic and diabetes care model diversity. These
clinics were matched by geographic location and patient sociodemographics to form the three study
groups. The patients were not randomly assigned; each patient was assigned to a study group based on the
clinic from which he or she was recruited.
The UC group featured two community clinics and represents the status quo of clinical practice, wherein
the translation and adoption of depression care evidence is performed by PCPs and their staffs. The SC and
TC groups each featured two care teams from an LACDHS diabetes disease management program (DMP)
to incorporate depression care. In both the SC and TC groups, one of the two teams practiced in both a
hospital-based outpatient clinic and a satellite community clinic; the other team practiced in a community
clinic in a different geographic area.
The intervention period was 12 months, and the study occurred from 2011 to 2013. During the first 6
months, the UC group received usual primary care, whereas the SC group received DMP-supported
depression care, and the TC group received the ATA application in the DMP setting. After 6 months, all
SC and TC patients were transferred back to their usual primary care, although the ATA calls were
continued for the full 12 months. This paper reports the 6-month outcomes.
Intervention Description Table 1 shows the intervention elements of the UC, SC, and TC models,

described below.
Usual Care Model The UC model was standard primary care. UC clinicians were offered an optional

training opportunity (described in Provider Training and Depression Treatment Protocol section below).
Supported Care Model The SC model used the diabetes DMP team (comprising nurse care managers,

nurse practitioners, and a consulting or supervising physician) to deliver depression care. SC diabetes care
management was designed to proactively identify, risk stratify, and treat patients using clinical protocols
that emphasized patient empowerment. The DMP was nurse driven and physician supervised and used
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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structured approaches and protocols; in these programs, nurses delivered the majority of the diabetes care.
The approaches included a patient-signed commitment to take an active role in his or her diabetes care,
case management, PCP designation, group patient education, self-management support, and care
coordination. The diabetes-specific management was provided initially via in-person visits, with follow-up
primarily via telephone visits. The DMP included a homegrown, Web-based, interactive chronic DMR
system to support clinical assessment and decisions. The DMP was designed for limited-time care
management (typically 6 months), after which patients were transferred back to their primary medical
providers.
During the study, the SC team supplemented diabetes management with two periodic depression symptom
screening and monitoring tools: (1) the 9-item Patient Health Questionnaire (PHQ-9) [58], a standard tool
in each clinic’s disease registry and (2) the LACDHS depression care protocol and treatment guideline (see
“Provider Training and Depression Treatment Protocol”). In PHQ-9, the patient scores each of the nine
Diagnostic and Statistical Manual of Mental Disorders, 4th edition criteria as “0” (not at all) to “3” (nearly
every day) to provide both a dichotomous diagnosis of probable major depression and a continuous
severity score [58]. The SC program also designated a social worker to provide problem-solving therapy
(PST), an evidence-based depression treatment [59].
Technology-Facilitated Care Model The TC model also operated in a DMP clinic setting with a DMR and

supplemental depression care based on the LACDHS depression care protocol and treatment guideline.
The TC model, however, was designed to assist time-pressured clinical social workers and medical and
nursing providers by using an ATA system to routinely screen and monitor patient depression symptoms
and treatment adherence and communicate the results to providers. As described elsewhere [33,52], the
ATA system was linked with the DMR to automatically trigger depression care management calls on a
predetermined calendar schedule. The call contents were individually tailored, driven by a preprogrammed
algorithm that scanned patient medical records and call histories to determine applicable questions. The
ATA used a persona, “Amy,” who spoke in a natural voice rather than a system-generated text-to-speech
robotic voice to administer the assessment questions. During study enrollment, patients selected their
preferred language (English or Spanish) and preferred call time. The DCAT ATA built in both automated
speech recognition and interactive voice response technologies [60] that allowed patients to either speak
their responses to Amy’s questions or punch numbers on a phone keypad. Automated speech recognition
has the advantage of eliminating number-punching errors, which are a concern for diabetes patients with
sensing or vision problems. Unfortunately, automated speech recognition was only available in English,
not Spanish, because of suboptimal recognition accuracy in different Spanish accents.
There were two main ATA call scripts: one for screening and one for monitoring. The screening calls were
for people who had no prior history of depression or who had been clear of a depression diagnosis for at
least 6 months. The ATA collected information in four categories: (1) depressive symptoms; (2) pain; (3)
self-management activities, including regular physical and fun activities; and (4) patient request to be
contacted by a provider. PHQ-2, the first two items of the PHQ-9, were used for screening; if a patient
score exceeded the cut-off of 3 points out of the possible 6 points, the ATA automatically asked the
remaining PHQ-9 items. The monitoring calls were for depressed patients; the monitoring calls addressed
all four categories and administered PHQ-9. If the patient had been prescribed an antidepressant, the call
asked questions about medication adherence and side effects. If the patient was receiving psychotherapy,
the call asked questions about problem-solving skills practice. Depending on the questions asked and
patient response time, each ATA call lasted about 2 to 5 min. If a patient did not answer the call, the ATA
system repeated the calling attempt multiple times a day for up to 1 week [52]. If a patient did not pick up
the call within a week, the scheduled call was forfeited, and the patient was contacted again for the next
scheduled call.

https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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The telephone was selected as the communication platform because phones were the most accessible
technology among safety-net patients at the time of the study. The calls were low intensity (ie, one call
every month for monitoring or every 3 months for screening based on each patient’s depression condition)
to balance information need and patient burden. Clinic officials have reported that patients who are
depressed seem more likely to miss their scheduled visit appointments and often delay or forgo calling for
help when symptoms fail to improve or worsen. The ATA system mitigated this dilemma by contacting
patients rather than relying on them to initiate calls, proactively reaching patients and identifying their care
needs. The TC model did accommodate patients who preferred a personal call over an automated call; in
those cases, staff members made the calls according to the patient’s language and schedule preferences
(25/366 or 6.8% of the patients made the request).
The patient-reported ATA data were tethered to the DMR, which in the TC model was enhanced by clinical
decision support software for provider collaborative communication. The decision support software
automatically generated task reminders and alerts based on the patient records in the DMR and the
assessment data; the reminders and alerts prompted DMP providers to follow up with specific patients in
need of care. For example, the automatically generated provider tasks in the DMR would remind a care
manager to follow up with a patient who self-reported an antidepressant adherence issue, task a social
worker to follow up with a patient with major depression symptoms, or task a nonclinical assistant to
address patient callback requests. Task reminders included structured, radio-button lists of potential care
management actions with the option of free text to support evidence-based practices and to ease providers’
documentation burden.
If a patient expressed an inclination toward self-harm or suicide (ie, responded to PHQ-9 question 9 with a
score of 2=more than half the days or 3=nearly every day), the ATA system automatically initiated contact
(via mobile phone SMS [short message service] text message and email) with an emergency response
physician to get help for the patient. If the physician did not respond within 15 min, the ATA system
initiated contact with the next physician on the emergency response team. This process repeated up to the
fifth physician (the first three were psychiatrists and the last two were emergency medicine physicians) to
ensure the patient received attention. During the study, the ATA was able to reach an emergency response
physician in every instance.
Provider Training and Depression Treatment Protocol DMP depression care in both SC and TC was

based on the LACDHS depression care protocol and treatment guideline, which was developed by the
DCAT team and described in the study design paper [33]. All SC and TC care providers were trained by an
expert psychiatrist in the collaborative depression care model and adaptive treatment approach via one of
three webinars (each approximately 2 hours). They were also offered training in PST via a 1-day (6-hour)
workshop conducted by an academic psychologist and a social worker faculty member who are PST
experts. UC providers were also invited to participate in these training opportunities, but they were not
given time off from clinical duties to participate in the trainings.
While TC used technology to support providers for depression symptom and treatment adherence
monitoring and to facilitate care coordination, SC providers monitored patients in the traditional way by
calling patients and coordinating care among themselves. All patients in the SC and TC groups received
support from a nurse care manager by telephone or in the clinic; in the TC group, patients also received the
ongoing follow-up ATA calls in English or Spanish. If a patient in either group was confirmed for
depression, weeks 1 to 8 of the depression care protocol included first-line treatment with antidepressant
medication prescribed according to the protocol by the treating physician or nurse practitioner. If the
patient refused medication, the care manager referred the patient to a social worker for six to eight PST
sessions.

https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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During weeks 9 to 12, the care manager would refer patients with a partial response (reduction in PHQ-9
scores) or nonresponse back to the treating physician or nurse practitioner, who would adjust
antidepressant medication dosage (or encourage nonmedicated patients to begin medication) and the
addition of PST. Patients with a full response (PHQ-9 score less than 8) received monthly treatment
maintenance and relapse-prevention behavioral activation.
Consistent with the depression care protocol, patients with persistent PHQ-9 scores of 10 or higher were
offered additional PST booster sessions; augmentation with low-dose trazodone, an antidepressant
medication that also helps treat anxiety and insomnia; or referrals to specialty mental health care.
Participant Eligibility and Recruitment
Textboxes 1 and 2 show the eligibility and ineligibility criteria for patients.
Eligibility criteria for patients.
Eligibility criteria
18 years or older
Had been diagnosed with type 2 diabetes
Had a working phone number
Spoke English or Spanish
Could read and understand the consent form

Ineligibility criteria for patients.
Ineligibility criteria
Patients with baseline possible suicidal ideation
Patients with cognitive impairment
Patients with alcohol abuse
Patients with recent lithium or antipsychotic medication

Every enrollee received a set of educational and community resource materials in Spanish or English.
The enrollment period was from April 2011 to May 2012. Patients with type 2 diabetes were identified for
recruitment from the DMR database and clinic records. Patients provided verbal consent to bilingual
research assistants during study eligibility screening.
Outcome Measures
Measures were taken at baseline and at 6, 12, and 18 months by independent English-Spanish bilingual
interviewers. Primary outcomes included three depression outcomes, five diabetes care measures, and six
patient-reported outcomes measuring physical and mental well-being, functional impairment, and
satisfaction with care (see Table 2).
Sample Size Calculation
The target sample size was based on power analysis for two primary outcomes: reduction of depressive
symptoms (measured by PHQ-9 score) and depression remission. Power analyses were conducted using
nQuery (Statistical Solutions Ltd, Boston MA) [65] to estimate effect sizes of the treatment with
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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nonrandomized pre- and postintervention comparisons and longitudinal statistical approaches for repeated
measures to compare trends in depression-related outcomes. The calculations assumed an alpha of .05,
power of 0.80, attrition rates less than 20% at each 6-month follow-up assessment up to 18 months, and
25% to 30% depression prevalence among patients with diabetes [25]. For pre- and postintervention
comparisons across all three program conditions, a sample size of approximately 500 in each study group
would allow detection of a small effect size of 0.1.
Statistical Analysis
All analyses were carried out according to the intention-to-treat rule consistent with standard practice in
most clinical trials. The propensity score method has proved to be an effective approach to analyzing
observational or quasi-experimental studies [66-70]. A propensity score is defined as the probability that a
patient is likely to receive treatment or control given the patient’s baseline characteristics. Patients with the
same propensity scores are like those in a randomized controlled trial.
The classical propensity score method is only applicable to two-way comparisons. Thus, we used a
generalized propensity score (GPS) method designed for comparing two or more interventions versus one
comparison group [71,72], wherein the GPS is defined as the conditional probability that a patient is likely
to be in a specific group given this patient’s baseline characteristics. As recommended [72], a multinomial
logistic regression was used to estimate GPSs. The model used study group as the dependent variable and
the measured baseline characteristics shown in Table 3 (see “Results”) as the independent variables. We
subsequently checked the distribution of the estimated GPSs because comparisons between groups are
suspect if substantial separation occurs between study groups [72-74].
Comparative treatment effects were estimated by linear or logistic regression models that used outcomes at
6 months as the dependent variable and study group, care team, outcome variables at baseline, two of the
three estimated GPSs, insulin use, HBA1c, age, gender, and preferred language as the independent
variables. Regression that includes estimated GPSs as covariates has been shown to be an effective tool to
adjust sample biases in observational or quasi-experimental studies [71,72]. Three care team variables
were used to adjust for differences among providers. Two of the three estimated GPSs adjusted for
imbalance in baseline characteristics. Insulin use, HBA1c, age, gender, and preferred language were
included because their effects on outcomes were of clinical interest; and their inclusion is consistent with
prior findings in behavioral and clinical factors associated with depression in patients with diabetes [75].
The coefficients of study group predicted comparative treatment effects while controlling for other
covariates. All statistical analyses were conducted at 0.05 significance level (two-tailed) using SAS (SAS
Institute Inc, Cary NC) software, version 9.3.

Results
Baseline Characteristics and Participant Flow
A total of 1704 patients were screened, of which 101 patients met the exclusion criteria, 128 patients
refused to participate, 12 patients did not sign the Health Insurance Portability and Accountability Act
agreement, and 57 patients were excluded after not completing the baseline assessment. Men had a
significantly lower enrollment rate than women (84.0% [536/638] vs 89.02% [949/1066], respectively;
P=.003), which was partly associated with poor alcohol use scores (4.9% [31/638] for men vs 0.56%
[6/1066] for women).
Among the 1406 patients enrolled in DCAT (484 in UC, 480 in SC, and 442 in TC), 1309 patients (416 in
UC, 461 in SC, and 432 in TC) had complete data in the measures used in estimating the GPSs after
interviews at baseline. As shown in Table 3, there were no significant differences in baseline depressive
symptoms measured by the PHQ-9 score, anxiety symptoms measured by the Brief Symptom Inventory
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable
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score, functional disability measured by the Sheehan Disability Scale (SDS), and the overall mental status
measured by the 12-item Short Form Survey mental score. SC and TC patients had higher HBA1c
compared with UC patients because the SC and TC patients were enrolled from the DMP program
designed for patients with severe diabetes. Other significant differences were diabetes self-care score and
psychological stress measures (economic stress, number of stressors, sum of stress level, diabetes
emotional burden, and diabetes regimen stress). The unbalanced samples were expected because of the
quasi-experimental design. A Consolidated Standards of Reporting Trials diagram outlining participant
flow is shown in Figure 1. See Multimedia Appendix 1 for comparison of baseline characteristics of
samples included in versus excluded from the regression analysis. No significant differences were
identified.
Six-Month Outcomes
With the final sample size of 1087 (341 in UC, 380 in SC, and 366 in TC) to evaluate intervention effects,
the study has the statistical power of 0.80 to detect an effect size of Cohen d=0.12, a small effect size.
Regression analysis with GPS adjustment results regarding 6-month outcomes in DCAT are shown in
Tables 4 and 5. The GPSs were estimated by the previously described multinomial logistic regression
model. The distributions of the estimated GPSs across study groups were similar; thus, treatment effects
can be predicted based on the estimated GPSs instead of actual group assignment.
Compared with UC, both SC and TC were significantly associated with decreased PHQ-9 scores (least
squares estimate, LSE: UC=6.35, SC=5.05, TC=5.16; P value: SC vs UC=.02, TC vs UC=.02) and reduced
prevalence of depression as measured by PHQ-9 ≥10 (SC vs UC: adjusted odds ratio, AOR=0.45, 95% CI
0.23-0.88, P=.02; TC vs UC: AOR=0.33, 95% CI 0.17-0.65, P=.007). Only TC was significantly
associated with improved depression remission relative to UC (AOR=2.98, 95% CI 1.08-8.25, P=.04),
although SC came close. There were no significant differences in depression outcomes between the SC and
TC groups.
Regarding diabetes care measures, no significant differences existed between SC and UC. However, TC
was significantly associated with reduced total cholesterol level (LSE: UC=176.40, TC=160.46; P=.01)
and increased odds that the patient would have an HBA1c test (TC vs UC: AOR=3.40, 95% CI 1.58-7.31,
P<.001). The latter was positively correlated with depression remission (AOR=2.67, 95% CI 1.15-4.17,
P=.004). There were no significant differences in diabetes care measures between the SC and TC groups.
Both SC and TC were significantly associated with improved SDS scores relative to UC (LSE: UC=3.21,
SC=2.61, TC=2.59; P value: SC vs UC=.04, TC vs UC=.03). SC was significantly associated with
improved satisfaction with care for emotional problems compared with UC (LSE: UC=3.25, SC=3.64;
P=.01), but only TC was significantly associated with improved satisfaction with diabetes care (LSE:
UC=4.01, TC=4.20; P=.05) and satisfaction with care for emotional problems among patients with
depression, as measured by PHQ-9 ≥10 at baseline (LSE: UC=3.20, TC=3.70; P=.05). There were no
significant differences in patient-reported outcomes between the SC and TC groups.

Discussion
Principal Findings
Analysis of 6-month DCAT outcomes revealed that both the TC and SC groups were significantly
associated with better outcomes compared with UC in terms of depressive symptoms reduction. Using the
PHQ-9 score, which ranges from 0 to 27, the 1.3 (SC group) and 1.2 (TC group) points of improvements
compared with the UC group are clinically meaningful given that the baseline PHQ-9 score is only about
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6.5 points. The magnitude of improvements is consistent with a recent collaborative depression care study
that included both depressed and nondepressed patients [80]. This finding supports the hypothesis that the
two intervention groups would be associated with better depression care outcomes.
It was not surprising to find the ATA technology did not improve depression outcomes of the TC group
over the SC group in this case because it was designed to facilitate the adoption of collaborative depression
care rather than direct clinical intervention with patients. Clinically, DMP care teams in both groups were
trained in and practiced the LACDHS depression protocol and treatment guideline. The SC DMP providers
monitored patients using traditional mechanisms (specifically by calling patients), and they coordinated
care among themselves; therefore, the study-related depression care resulted in additional new workload
for the SC providers. For the TC care team, the technology, albeit at a low-intensity of contact, helped
alleviate the workload for depression symptom and treatment adherence monitoring.
The ATA technology also prompted providers to follow up and alerted emergency responders to
immediately contact patients with suicidal ideation. That could be the reason why only the TC group was
significantly associated with depression remission and increased patient satisfaction among depressed
patients. The results are encouraging that a well-designed technology can be an effective aide to the
adoption of collaborative depression care. Full justification of the TC model via a complete costeffectiveness analysis is presented elsewhere [56]. The cost-effectiveness analysis revealed that the
intervention models improved quality-adjusted life years, depression-free days, and medical costs. The TC
model was cost-effective compared with SC and cost-saving compared with UC. The 6-month and costeffectiveness results suggest the TC model is promising in facilitating better and cost-effective care for
depressed patients.
Moreover, only the TC model was significantly associated with improved diabetes care processes,
indicated by reduced total cholesterol level and increased odds that the patient would have an HBA1c test.
One possible explanation for these improvements in diabetes care is that as depressive symptoms are
increasingly monitored and timelier addressed, patients may become more willing to take active care of
their diabetes; this explanation is supported by the significant correlation between the odds of having an
HBA1c test and the improvement in depression remission. Another possible explanation is that providers
may address patients’ diabetes care needs in addition to depression care needs when they respond to the
task reminders generated by the technology.
Compared with the UC group, both the SC and TC models were significantly associated with better
improvement in 6-month patient-reported functioning in family, work, and social life, as measured by the
3-item SDS. The 0.6 points of improvements in SC and TC groups compared with the UC group are
meaningful as most patients at baseline had only minimal functional impairment (average baseline SDS
score was 2.1 points; SDS score >6 indicates functional disability [63,64]), which implies that the room for
improvement is small. This finding suggests that the two enhanced care delivery models not only
improved depressive symptoms but also translated such symptom improvement into better perceived life
functioning.
While the TC model delivered positive results, and most patients in the TC groups reported high
acceptance of the ICT tested in DCAT [51], there is significant room for improvement in using the ATA
technology. Specifically, only half of the scheduled calls were answered successfully because of phone
connectivity issues or lack of time for the patient to answer the calls [50,52]. One challenge may have been
that during the study, most patients in LACDHS did not use cellphones. Now that cellphones are more
readily available, attention should be turned to other ICT (such as SMS text messages and smartphone
apps) to improve patient contact and to capture patient-reported outcomes. Such technology has greater
portability and versatility, may extend the ATA capabilities in reaching and engaging patients, may
potentially increase the model effectiveness, and may reduce costs.
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Researchers can expect unpredictable consequences after making changes (such as the DCAT
implementation) in complex systems such as LACDHS. As discussed in another DCAT study [53], two
particularly important implications that emerged were the strengthened role of social workers (in both SC
and TC) and the importance of suicide-alert responders (in TC). Every DMP site had a colocated clinical
social worker, an evidence-based method of improving quality of depression care [81,82]. The clinical
social workers were an underutilized resource before the study; during the DCAT trial, they proved
instrumental in adopting depression care. Furthermore, the suicide-alert responders appeared to play a
much larger role than anticipated. Providers facing typical barriers in mental health care (including lack of
familiarity with guidelines, lack of self-efficacy, and lack of outcome expectancy [83]) were reassured by
the availability of an organizational resource for the patient to fall back on in the “worst case scenario,”
namely severe suicidal ideation. Taken together with the strengthened role of the social worker, the
interventions seemed to have leveraged the available mental health resources into a more cohesive,
integrated model of mental health care in a primary setting. In other words, the SC and TC models used
existing diabetes disease management teams and leveraged available mental health resources to implement
depression symptom monitoring and treatment protocols, provider collaborative communication, and
patient relapse prevention.
In summary, the 6-month DCAT findings suggest that both the TC and SC delivery models are
significantly associated with improved depression outcomes and life functioning, and that the TC model
offers additional promise in terms of improved depression remission, diabetes care processes, and patient
satisfaction. Given the rapid rise of diabetes during the past several decades—especially among lowincome, minority populations—and the immense opportunity to improve diabetes-related measures and
outcomes, a growing number of health plans and health care organizations are trying to manage their
diabetes population through disease management programs. The SC and TC models demonstrated that an
important and valuable way to support providers is to add evidence-based collaborative depression care
and facilitate adoption of ICT in diabetes DMPs designed to reduce disparities in commonly comorbid
diabetes and depression care. When enhanced by ICT, DMPs may be able to greatly improve overall care,
cost, and effectiveness of health care delivery for underserved patients. DCAT SC and TC models
improved diabetes and depression outcomes in the second largest US safety-net health system; other
resource-constrained programs may replicate these models to improve comorbid diabetes and depression
outcomes.
Limitations
The main limitation of this study is its employment of a quasi-experimental design, which introduces bias
because of the differences in both patient characteristics and care teams at each facility. To mitigate the
bias, in the regression analysis we adjusted for patient differences through propensity scores and the
assignment of the six care teams at eight facilities (each facility was staffed by only one team; two of the
six teams served two facilities). Although care facilities were matched by geographic location and patient
sociodemographics among the three study groups, the quality of care can vary from facility to facility;
therefore, the regression analysis included a check in which care team assignments were replaced for each
facility. This analysis did not change the direction and significance of intervention effects; however, the
adjustment may not be sufficient. Differences in the facilities, the DMP care teams, and the unmeasured
patient sociodemographics, diabetes and comorbid conditions, and psychological stress measures may
differentiate diabetes and depression care needs and outcomes [84]. Providers should consider these
differences when applying the technology.
Another limitation may be the predominantly Latino sample, which raises concern about the
generalizability of findings. Applying the DCAT TC model to other groups should be done cautiously and
with further evaluation.
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The third limitation is the focus in this paper on clinical outcomes. However, the DCAT TC model was
designed to accelerate the adoption of evidence-based collaborative care to improve the overall care
process. Full analyses of 18-month clinical outcomes and the cost-effectiveness of the TC model will be
reported elsewhere.
The fourth limitation is lack of data to understand the practical mechanism by which the SC DMP and the
technology-enhanced TC DMP led to improvements in depression. Possible improvement mechanisms for
future research include better treatment initiation or adjustment, receipt of PST, greater patient adherence,
or referrals and visits to other mental health providers.
Comparison With Prior Work
DCAT adds to the growing number of telehealth studies that are employing technology to improve
depression care in primary care settings for patients with chronic diseases [85-92]. A key strength of the
DCAT TC model over earlier studies is that it used automated calls, which reduces provider depression
monitoring workload and allows more time for clinical encounters such as timely adjustment of treatment.
The TC model is especially effective in a resource-constrained environment such as safety-net care
systems, improving care for predominantly minority and low-income patients.
Applying automated remote monitoring ICT, electronic clinical decision support, and even artificial
intelligence to facilitate chronic disease management is an emerging research topic. Prior studies revealed
that ATA is valid in conducting depression screening and suggested the technology can be incorporated
into the care management model [93,94]. However, evidence is limited regarding the comparative
effectiveness of the technology. Kroenke et al [95] tested ATA with care management for pain and
depression in patients with cancer; Ratanawongsa et al [96] and Handley et al [97] tested ATA-facilitated
diabetes management for low-income Medicaid and safety-net patients. The DCAT study uniquely
addressed depression care for patients with type 2 diabetes in a safety-net setting where comorbidity of the
two diseases is common and where many barriers such as culture diversity, financial stress, and limited
provider resources impede the adoption of evidence-based depression interventions. Results from DCAT
are consistent with prior studies [91-97] and support ATA as a promising technology to facilitate care
management, even for sensitive conditions such as depression, for diverse populations and in primary care
settings.
Conclusions
Both SC and TC models are associated with improved 6-month depression outcomes and reduced
functional disability among adult patients with type 2 diabetes. However, the TC model is more likely to
achieve greater improvements in depression remission, as well as measures of patient satisfaction and
diabetes care quality. This paper provides encouraging evidence that a well-designed automated ICT
system is an effective facilitator that can support delivery of evidence-based collaborative depression care
to patients with type 2 diabetes in a resource-constrained urban safety-net primary care setting. This is a
promising solution to reduce health disparities, improve patient experience of care, and improve the health
of low-income, minority populations.
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adjusted odds ratio
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Table 1
Intervention elements of the usual care (UC), supported care (SC), and technology-facilitated care
(TC) models. ATA: automated telephone assessment; DMP: disease management program; DMR:
disease management registry; LACDHS: Los Angeles County Department of Health Service; PCP:
primary care physicians; PHQ-9: 9-item Patient Health Questionnaire; PST: problem-solving
therapy.
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Elements

Usual care

Supported care

Care paradigm

Standard primary care; optional PST

Diabetes DMP-supported care; PST; Inte
DMR system

Clinic setting

Two community non-DMP clinics

Two diabetes DMP teams in safety-net cl
serving both hospital-based outpatient cli
satellite community clinic, and other serv
community clinic in a different geograph

Patient

Depression educational pamphlets (in English) or

Depression educational pamphlets (in En

education and

fotonovella (in Spanish) adapted for diabetes

fotonovella (in Spanish) adapted for diab

care resources

patients; Standard provider contact and community

patients; Standard provider contact and c

resource information

resource information

Physician

Psychiatrist expert conducts webinars about

Psychiatrist expert conducts webinars abo

education

collaborative depression care evidence, offers PCP

collaborative depression care evidence, o

depression screening and treatment didactic, and

depression screening and treatment didac

provides personal copy of the Los Angeles County

provides personal copy of the Los Angele

Department of Health Services depression care

Department of Health Services depressio

protocol

protocol

Optional for UC clinicians

Mandatory for DMP nurses, nurse practit

Clinician
training for

social workers; conducted by psychology

PST

work experts

Depression

Standard care determined by PCP practice

Performed by DMP clinical social worke

screen and

screening when patients join the DMP; O

ongoing

symptom monitoring per clinical judgme

symptom

LACDHS depression care protocol and tr

monitoring

guideline

Depression

Standard care: Antidepressant medication; Referral

DMP based on the LACDHS protocol an

treatment

to clinic social worker or community mental health

guideline: Antidepressant with optional P

care

of community referrals

LACDHS standard clinic collaboration

DMP nurse initiates communication with

Provider
collaborative

prescriber; Refers patient to social worke

communication

refuses medication or needs PST

Open in a separate window
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Table 2
Primary outcome measures in the Diabetes-Depression Care-management Adoption Trial (DCAT),
Los Angeles, 2011 to 2013. HBA1c: glycated hemoglobin; PHQ-9: 9-item Patient Health
Questionnaire; PST: problem-solving therapy; SF-12: 12-item Short Form Survey.
Variables

Description

Depression, measured at baseline and
6 months post intervention
PHQ-9 [58]

Continuous variable assessing severity of depression. Scoring: PHQ-9 of 5PHQ-9 of 15-19=major depression; PHQ-9 of 20-27=severe depression. Fo
enough to consider pharmacologic or PST treatment.

Depression remission

Dichotomous variable assessing effectiveness of treating patients with majo
≥10 and 6-month PHQ-9 ≤8 with a reduction ≥50%.

Diabetes, measured at baseline and 6
months post intervention if not
otherwise indicated
a
HBA1c value
a
HBA1c tested
a
Total cholesterol

Continuous variable assessing severity of diabetes. HBA1c value indicates
Dichotomous variable assessing diabetes care process.
Continuous variable assessing cholesterol levels and severity of dyslipidem

Diabetes self-care [61]

Days per week of diabetes self-care. Treated as a continuous variable.

Exercise

Days of participating in at least 30 min of exercise during previous week.

Patient reported outcomes, measured
at baseline and 6 months post
intervention
SF-12 physical score [62]

Continuous variables assessing functional health and well-being

SF-12 mental score [62]
Sheehan Disability Scale [63,64]

Self-reported tool assessing functional impairment in work or school, socia

Satisfaction with diabetes care

Five-level score assessing diabetes care satisfaction. Treated as a continuou

Satisfaction with care for emotional

Five-level score assessing mental health care satisfaction. Treated as a cont

problems
Satisfaction with care for emotional

Five-level score assessing mental care satisfaction of patients with major de

problems, baseline PHQ-9 ≥10

Open in a separate window
aThe HBA value, HBA tested, and total cholesterol value were obtained from the LACDHS electronic medical
1c
1c

record system. The measurement periods were within 3 months of baseline and 6-month post intervention. If more
than one value was available, the values closest to the baseline and the 6-month follow-up period were chosen.
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Table 3
Descriptive of baseline measures used in estimating the generalized propensity scores. PHQ-9: 9item Patient Health Questionnaire; SC: supported care; SF-12: 12-item Short Form Survey; TC:
technology-facilitated care; UC: usual care.
Baseline characteristic

a
a
Usual care (n=416) Supported care (n=461) Tech

Age in years, mean (SD)

55.15 (9.21)

51.92 (9.29)

52.63

Female, n (%)

293 (70.4)

271 (58.8)

266 (

Latino, n (%)

389 (94.0)

386 (83.7)

390 (

Spanish as preferred language, n (%)

366 (88.0)

360 (78.1)

352 (

Body mass index, mean (SD)

32.55 (7.04)

32.73 (7.64)

33.11

Less than high school education, n (%)

310 (74.5)

287 (62.3)

306 (

Unemployed, n (%)
b
Economic distress , mean (SD)
c
Number of stressors , mean (SD)
d
Sum of stress level , mean (SD)
e
Predicted future health cost , mean (SD)

275 (66.1)

30 (67.0)

286 (

3.91 (2.44)

3.76 (1.98)

4.35

2.16 (2.20)

2.57 (2.30)

2.54

14.50 (16.23)

19.26 (19.49)

17.16

6711.47 (3347.32)

6839.82 (3854.07)

6376

Age at onset of diabetes, mean (SD)

45.20 (10.52)

41.84 (10.19)

42.32

Insulin use, n (%)

114 (27.4)

310 (67.2)

282 (

SF-12 physical, mean (SD)

43.24 (11.19)

45.83 (10.91)

43.96

SF-12 mental, mean (SD)

50.09 (12.12)

49.33 (14.16)

50.39

0.71 (0.45)

0.73 (0.44)

0.65

1.67 (0.63)

1.71 (0.63)

1.56

2.75 (1.96)

3.69 (2.08)

2.53

2.61 (1.91)

3.61 (2.11)

2.40

4.04 (1.34)

4.76 (1.24)

4.23

6.55 (5.51)

6.80 (6.43)

6.44

1.32 (3.02)

1.27 (3.24)

0.98

2.19 (2.80)

2.10 (3.00)

2.06

Dysthymia, n (%)

55 (13.2)

116 (25.2)

64 (1

Previous diagnosis of major depressive disorder, n (%)

23 (5.5)

75 (16.3)

17 (3

Chronic pain, n (%)

127 (30.5)

129 (28.0)

71 (1

Satisfaction with diabetes care, mean (SD)

4.61 (0.74)

4.81 (0.50)

4.67

f
Number of diabetes complications , mean (SD)
g
Whitty-9 diabetes symptoms scale , mean (SD)
h
Diabetes emotional burden , mean (SD)
h
Diabetes regimen stress , mean (SD)
i
Diabetes self-care , mean (SD)
j
PHQ-9 , mean (SD)
k
Brief Symptom Inventory , mean (SD)
l
Sheehan Disability Scale , mean (SD)

Open in a separate window
a

Values are numbers (column percentage) for categorical variables and mean (SD) for continuous variables.

b

Assessed by 12 general and health-related economic distresses, scored 0-12; higher scores indicate a higher level of
economic distress.
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c

Assessed by 12 stressors related to work, family, social, and legal problems, scored 0-12; higher scores indicate a
larger number of stressors.

dAssessed by 12 stressors related to work, family, social, and legal problems, each rated by level of stress from 0-10;

therefore, total scores range from 0-120, with higher scores indicating a higher level of stress.
e

Prediction of future health cost using the RxRisk model [76].

f

Assessed by 7 diabetes complications: vision problems, loss of feeling in feet or legs, kidney problems, foot ulcer,
amputation, sexual impairment, and heart attack, scored 0-7; higher scores indicate a larger number of diabetes
complications.
gAssessed by the 9-item diabetes symptoms scale [77], scored 1-5; higher scores indicate more severe diabetes.
h

Assessed by the 2-item Diabetes Distress Scale [78], scored 1-6; higher scores indicate a higher level of diabetes
distress.
i

Assessed by the Toobert Diabetes Selfcare Scale [61], scored 0-7; higher scores indicate better diabetes self-care.

j

Assessed by the 9-item Patient Health Questionnaire [58], scored 0-27; higher scores indicate worse depressive
symptoms.
k

Assessed by the Brief Symptoms Inventory [79], scored 0-24; higher scores indicate worse anxiety.

lAssessed by the Sheehan Disability Scale [63,64], scored 0-30; higher scores indicate more significant functional

impairment.
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Figure 1

Consolidated Standards of Reporting Trials (CONSORT) diagram: participant flow of Diabetes-Depression CareManagement Adoption Trial (DCAT).

https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC5938593/?report=printable

31/33

3/12/2019

Comparative Effectiveness of a Technology-Facilitated Depression Care Management Model in Safety-Net Primary Care Patients With T…

Table 4
Regression analysis of continuous 6-month outcomes adjusted for baseline characteristics and
propensity scores in the Diabetes-Depression Care-management Adoption Trial (DCAT), Los
Angeles, 2011 to 2013. Linear regression models are adjusted for care team, outcome variable at
baseline, two of the three estimated generalized propensity scores, insulin use, glycated hemoglobin
(HBA1c), age, gender, and preferred language. Least squares means and SE reported for continuous
outcomes. LSE: least squares estimate; PHQ-9: 9-item Patient Health Questionnaire; SC: standard
care; SF-12: 12-item Short Form Survey; TC: technology-facilitated care; UC: usual care.
Continuous outcome

Usual care

Supported

Technology-

SC vs TC vs TC vs

(n=341),

care (n=380),

facilitated care

UC

UC

SC

LSE (SE)

LSE (SE)

(n=366), LSE (SE)

(P

(P

(P

value) value) value)
PHQ-9

6.35 (0.49)

5.05 (0.47)

5.16 (0.48)

.02

.02

.81

HBA1c value

7.95 (0.17)

7.79 (0.16)

8.05 (0.16)

.41

.57

.10

Total cholesterol

176.40

166.90 (4.96)

160.46 (5.04)

.12

.01

.16

(5.27)
Diabetes self-care

4.66 (0.13)

4.70 (0.12)

4.78 (0.12)

.80

.38

.52

Exercise

4.73 (0.28)

4.90 (0.26)

4.86 (0.27)

.59

.66

.88

SF-12 physical score

42.99 (0.97) 42.46 (0.95)

41.87 (0.95)

.63

.27

.55

SF-12 mental score

48.38 (1.04) 50.07 (1.01)

49.87 (1.02)

.16

.17

.85

Sheehan Disability Scale

3.21 (0.26)

2.61 (0.25)

2.59 (0.25)

.04

.03

.95

Satisfaction with diabetes care

4.01 (0.09)

4.15 (0.09)

4.20 (0.09)

.17

.05

.58

Satisfaction with care for emotional

3.25 (0.10)

3.64 (0.10)

3.46 (0.10)

.01

.07

.06

3.20 (0.22)

3.58 (0.21)

3.70 (0.21)

.16

.05

.56

problems
Satisfaction with care for emotional
problems, among patients with
baseline PHQ-9 ≥10
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Table 5
Regression analysis of binary 6-month outcomes adjusted for baseline characteristics and
propensity scores in the DCAT, Los Angeles, 2011-2013. Logistic regression models are adjusted
for care team, outcome variable at baseline, two of the three estimated generalized propensity
scores, insulin use, glycated hemoglobin (HBA1c), age, gender, and preferred language. Adjusted
odds ratio (AOR) and 95% CIs reported for binary outcomes. PHQ-9: 9-item Patient Health
Questionnaire
Binary outcome

Supported care vs usual care

Technology-facilitated care vs usual care

AOR (95% CI)

P value

AOR (95% CI)

P value

PHQ-9≥10

0.45 (0.23-0.88)

.02

0.33 (0.17-0.65)

.007

Depression remission
a
HBA1c tested

2.86 (0.98-8.40)

.06

2.98 (1.08-8.25)

.04

1.82 (0.89-3.71)

.10

3.40 (1.58-7.31)

<.001

a

Adjusted relative risk for HBA1c tested, supported care vs usual care=1.13 (0.97-1.23), technology-facilitated care vs
usual care=1.22 (1.10-1.29), technology-facilitated care vs supported care=1.12 (0.95-1.21).
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